A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
Clinical trial NCT03011892 · COMPLETED
Trial details
- NCT number
- NCT03011892
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-09
- Primary completion
- 2018-01-10
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.